Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate
Hyperlipidemia has been frequently recorded as a side effect of treating HIV patients with protease inhibitors (PI). This study was initiated to analyze the modifications on blood lipids in HIV-patients receiving PI and the safety and efficacy of the treatment with fenofibrate. Total (TC) and HDL-ch...
Main Authors: | Bruno Caramelli, Claudia Y.S.M. de Bernoche, Ana M. C. Sartori, Andrei C. Sposito, Raul D. Santos, Maristela C. Monachini, Tania Strabelli, Davi Uip |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
|
Series: | Brazilian Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000600007&lng=en&tlng=en |
Similar Items
-
Effects of Oral Administration of Atorvastatin or Fenofibrate on Hyperlipidemia Induced by Betamethasone Dipropionate Injection in Rabbits
by: Sameh El Nabtity, et al.
Published: (2023-07-01) -
Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats
by: Ana Soria, et al.
Published: (2002-01-01) -
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
by: Stephan C, et al.
Published: (2010-09-01) -
Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
by: Michel Farnier
Published: (2008-10-01) -
Hypolipidemic effect of aqueous extract from the leaves of Artocarpus altilis "breadfruit" in Rattus norvegicus induced hyperlipidemia
by: Julio Campos Florián
Published: (2013-12-01)